U.S. Trade Rep’s IP Report: China Always Improving, Never Enough
This article was originally published in The Pink Sheet Daily
Executive Summary
Chinese officials’ seem able control piracy when they want to, as they did during the Beijing Olympics, but may be loosening up enforcement to protect jobs during the economic crisis, U.S. official says.
You may also be interested in...
South Korea-U.S. Free Trade Agreement Likely To Put Stranglehold On Local Korean Drug Makers
SEOUL - South Korean pharmaceutical companies are bracing for a tough time ahead if the governments of South Korea and the U.S. ratify a long-awaited Free Trade Agreement hammered out last year after eight rounds of negotiations between the two countries
China Pledges To Accelerate Drug Reimbursement Process
China has agreed to update its national and regional drug reimbursement lists every two years, which should expand market access for new drugs developed by multinational companies
Sanofi Asks Thailand To Review Compulsory Licensing Policy
Sanofi-Aventis sent a request to the previous Thai Minister of Commerce Mingkwan Sangsuwan to review the process of compulsory licensing on patented drugs, Graham Almond, Sanofi-Aventis Thailand general manager told PharmAsia News.